• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌部分胃切除术后对幽门螺杆菌自发消失的影响:一项单中心前瞻性研究。

The influence of partial gastrectomy for gastric cancer on the spontaneous disappearance of Helicobacter pylori: A single-center prospective study.

机构信息

Department of Surgery, Onomichi General Hospital, Hiroshima, Japan.

Department of Digestive Surgery, Hiroshima Prefectural Hospital, Hiroshima, Japan.

出版信息

Cancer Rep (Hoboken). 2023 Dec;6(12):e1903. doi: 10.1002/cnr2.1903. Epub 2023 Sep 12.

DOI:10.1002/cnr2.1903
PMID:37697944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10728519/
Abstract

BACKGROUND/AIMS: Helicobacter pylori (HP) eradication is recommended after endoscopic treatment of early gastric cancer (EGC). Cases of spontaneous HP resolution after partial gastrectomy due to environmental changes have been reported; however, there is no evidence for the efficacy of HP eradication in suppressing carcinogenesis and also no reports on the natural history of HP after partial gastrectomy in gastric cancer (GC). To report the natural history of HP in patients with GC and HP infection after partial gastrectomy.

METHODS AND RESULTS

We prospectively studied the rate of spontaneous disappearance of HP after partial gastrectomy in patients with GC. From April 2016 to May 2020, 80 patients underwent partial gastrectomy, including 9 cases of proximal gastrectomy (PG), and 71 cases of distal gastrectomy (DG). The presence of HP was confirmed in the stool antigen test 1 year after operation, HP infection persisted in 46 patients (57.5%) and disappeared in 34 patients (42.5%). In univariate analysis, only proton pump inhibitor (PPI) use was a significant contributing factor for the spontaneous resolution of HP infection, especially in the DG group. However, there was no difference in the rates of HP disappearance between Billroth-I and Roux-en-Y reconstructions in the DG group.

CONCLUSION

The HP spontaneously disappeared in 42.5% of the GC patients within 1 year after partial gastrectomy. Further investigation in a larger cohort is needed to elucidate the underlying mechanisms.

摘要

背景/目的:幽门螺杆菌(HP)的根除推荐用于早期胃癌(EGC)的内镜治疗后。有报道称,由于环境变化,部分胃切除术后 HP 会自发清除;然而,尚无关于 HP 根除抑制癌变的疗效的证据,也没有关于胃癌(GC)部分胃切除术后 HP 自然史的报告。本研究旨在报告 GC 患者和 HP 感染患者部分胃切除术后 HP 的自然史。

方法和结果

我们前瞻性研究了 GC 患者部分胃切除术后 HP 自发消失的比率。2016 年 4 月至 2020 年 5 月,80 例患者接受了部分胃切除术,包括 9 例近端胃切除术(PG)和 71 例远端胃切除术(DG)。术后 1 年通过粪便抗原试验确认 HP 的存在,46 例患者(57.5%)存在 HP 感染,34 例患者(42.5%)HP 消失。单因素分析发现,只有质子泵抑制剂(PPI)的使用是 HP 感染自发清除的显著影响因素,尤其是在 DG 组。然而,在 DG 组中,Billroth-I 和 Roux-en-Y 重建之间的 HP 消失率没有差异。

结论

在部分胃切除术后 1 年内,42.5%的 GC 患者的 HP 自发消失。需要进一步在更大的队列中进行研究以阐明潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debc/10728519/1abfe2689fec/CNR2-6-e1903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debc/10728519/f63f7620df14/CNR2-6-e1903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debc/10728519/1abfe2689fec/CNR2-6-e1903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debc/10728519/f63f7620df14/CNR2-6-e1903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debc/10728519/1abfe2689fec/CNR2-6-e1903-g001.jpg

相似文献

1
The influence of partial gastrectomy for gastric cancer on the spontaneous disappearance of Helicobacter pylori: A single-center prospective study.胃癌部分胃切除术后对幽门螺杆菌自发消失的影响:一项单中心前瞻性研究。
Cancer Rep (Hoboken). 2023 Dec;6(12):e1903. doi: 10.1002/cnr2.1903. Epub 2023 Sep 12.
2
Characteristic analysis of early gastric cancer after eradication: a multicenter retrospective propensity score-matched study.根治术后早期胃癌的特征分析:一项多中心回顾性倾向评分匹配研究。
Ann Med. 2023 Dec;55(1):2231852. doi: 10.1080/07853890.2023.2231852.
3
Spontaneous clearance of Helicobacter pylori colonization in patients with partial gastrectomy: correlates with operative procedures and duration after operation.胃部分切除术后幽门螺杆菌定植的自然清除:与手术方式及术后时间的相关性
J Formos Med Assoc. 2009 Jan;108(1):13-9. doi: 10.1016/S0929-6646(09)60027-9.
4
Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years.胃大部切除术后根除幽门螺杆菌对胃癌患者生存率的影响:长达15年的随访
Gastric Cancer. 2020 Nov;23(6):1051-1063. doi: 10.1007/s10120-020-01076-2. Epub 2020 May 2.
5
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.根除幽门螺杆菌是否能降低早期胃癌胃切除术后残胃的癌变风险?幽门螺杆菌根除前后残胃黏膜病变的比较。
Langenbecks Arch Surg. 2004 Apr;389(2):83-91. doi: 10.1007/s00423-003-0451-x. Epub 2004 Feb 6.
6
Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.幽门螺杆菌根除对胃癌远端胃切除术后长期生存的影响。
Cancer Res Treat. 2016 Jul;48(3):1020-9. doi: 10.4143/crt.2015.264. Epub 2015 Nov 17.
7
Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.胃癌患者胃大部切除术后幽门螺杆菌根除治疗后的根除率及组织学变化。
World J Gastroenterol. 2015 Apr 7;21(13):3936-43. doi: 10.3748/wjg.v21.i13.3936.
8
Behavior of the infection by Helicobacter pylori of the gastric remnant after subtotal gastrectomy and Roux-en-Y anastomosis for benign diseases.胃大部切除及Roux-en-Y吻合术治疗良性疾病后胃残端幽门螺杆菌感染的行为
J Gastrointest Surg. 2008 Sep;12(9):1508-11. doi: 10.1007/s11605-008-0571-2. Epub 2008 Jul 9.
9
Effect of partial gastrectomy on serum anti-Helicobacter pylori immunoglobulins in peptic ulcer patients.胃部分切除术对消化性溃疡患者血清抗幽门螺杆菌免疫球蛋白的影响。
Dig Dis Sci. 1991 Dec;36(12):1697-701. doi: 10.1007/BF01296612.
10
The Effect of Helicobacter pylori Eradication on Gastric Wall Thickness in Patients Undergoing Laparoscopic Sleeve Gastrectomy.腹腔镜袖状胃切除术患者中幽门螺杆菌根除对胃壁厚度的影响。
Obes Surg. 2021 Sep;31(9):4024-4032. doi: 10.1007/s11695-021-05513-8. Epub 2021 Jun 1.

本文引用的文献

1
Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition).日本胃癌治疗指南 2021(第 6 版)。
Gastric Cancer. 2023 Jan;26(1):1-25. doi: 10.1007/s10120-022-01331-8. Epub 2022 Nov 7.
2
Role of New Anatomy, Biliopancreatic Reflux, and Helicobacter Pylori Status in Postgastrectomy Stump Cancer.新解剖学、胆胰反流和幽门螺杆菌状态在胃切除术后残端癌中的作用
J Clin Med. 2022 Mar 9;11(6):1498. doi: 10.3390/jcm11061498.
3
Comparison of Billroth I, Billroth II, and Roux-en-Y reconstructions following distal gastrectomy: A systematic review and network meta-analysis.
胃远端切除术后毕罗氏Ⅰ式、毕罗氏Ⅱ式和 Roux-en-Y 重建术的比较:系统评价和网络荟萃分析。
Cir Esp (Engl Ed). 2021 Jun-Jul;99(6):412-420. doi: 10.1016/j.cireng.2020.09.018.
4
Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome.非血液恶性肿瘤的常规骨髓抑制化疗会破坏肠道微生物组。
BMC Cancer. 2021 May 22;21(1):591. doi: 10.1186/s12885-021-08296-4.
5
Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years.胃大部切除术后根除幽门螺杆菌对胃癌患者生存率的影响:长达15年的随访
Gastric Cancer. 2020 Nov;23(6):1051-1063. doi: 10.1007/s10120-020-01076-2. Epub 2020 May 2.
6
Infection following Endoscopic Resection of Early Gastric Cancer.内镜下切除早期胃癌后的感染。
Biomed Res Int. 2019 Oct 16;2019:9824964. doi: 10.1155/2019/9824964. eCollection 2019.
7
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.日本幽门螺杆菌感染管理指南:2016 年修订版。
Helicobacter. 2019 Aug;24(4):e12597. doi: 10.1111/hel.12597. Epub 2019 May 20.
8
Precision surgical approach with lymph-node dissection in early gastric cancer.早期胃癌的精准外科手术与淋巴结清扫。
World J Gastroenterol. 2019 Apr 14;25(14):1640-1652. doi: 10.3748/wjg.v25.i14.1640.
9
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗(FLOT4):一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
10
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.多西他赛联合口服氟嘧啶可提高 III 期胃癌患者的疗效:JACCRO GC-07 随机对照试验的中期分析。
J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29.